TradeOrgs
  • Stocks
  • Screener
  • Backtest
  • Watchlist
  • Signals
  • Portfolio
  • Insights
  • Connect
Sign in
RELIANCE₹1,304.00▼ 0.70%TCS₹2,093.50▼ 6.61%HDFCBANK₹801.05▲ 6.29%ICICIBANK₹1,411.40▲ 13.64%INFY₹1,047.20▼ 14.35%HINDUNILVR₹2,201.20▲ 5.29%ITC₹289.95▲ 4.68%SBIN₹1,040.00▲ 7.17%BHARTIARTL₹1,910.40▲ 4.73%KOTAKBANK₹396.75▲ 4.13%LT₹4,026.60▲ 1.86%AXISBANK₹1,342.10▲ 6.92%ASIANPAINT₹2,737.80▲ 2.83%MARUTI₹14,366.00▲ 10.13%AAPL$308.63▼ 2.08%MSFT$390.49▼ 11.52%GOOGL$359.91▼ 0.54%AMZN$242.67▼ 5.40%NVDA$194.83▼ 12.56%META$582.90▼ 2.46%TSLA$393.45▼ 7.15%BRK-B$507.78▲ 7.69%JPM$334.47▲ 11.13%V$362.13▲ 14.12%
RELIANCE₹1,304.00▼ 0.70%TCS₹2,093.50▼ 6.61%HDFCBANK₹801.05▲ 6.29%ICICIBANK₹1,411.40▲ 13.64%INFY₹1,047.20▼ 14.35%HINDUNILVR₹2,201.20▲ 5.29%ITC₹289.95▲ 4.68%SBIN₹1,040.00▲ 7.17%BHARTIARTL₹1,910.40▲ 4.73%KOTAKBANK₹396.75▲ 4.13%LT₹4,026.60▲ 1.86%AXISBANK₹1,342.10▲ 6.92%ASIANPAINT₹2,737.80▲ 2.83%MARUTI₹14,366.00▲ 10.13%AAPL$308.63▼ 2.08%MSFT$390.49▼ 11.52%GOOGL$359.91▼ 0.54%AMZN$242.67▼ 5.40%NVDA$194.83▼ 12.56%META$582.90▼ 2.46%TSLA$393.45▼ 7.15%BRK-B$507.78▲ 7.69%JPM$334.47▲ 11.13%V$362.13▲ 14.12%

TradeOrgs shows market information and analyzes your own trading history. It does not place trades and is not investment advice.

Prices and listings are for information only. We are read-only against your broker account.

Technical signals (RSI, MACD, etc.) are educational readouts of public indicators — not recommendations.

Privacy Policy·© 2026 TradeOrgs

← All stocks

🇺🇸AARD

Aardvark Therapeutics, Inc. - Common Stock

NASDAQ
$5.70
▲ $1.73 (+43.6%)
Live· just now
delayed feed · not for order timing

Price history · 20-day (cyan) / 50-day (purple) avg

as of 02 Jul 2026
H $16.60L $3.35-60.8%
$16.6$13.95$11.3$8.65$6$3.35$5.7
RSI (14)
Intraday · 15-minNeutral+5RSI 64SidewaysMACD Bullishfor day-trading context — not advice

Technical signal

Neutral0
RSI (14)68
oversold 30overbought 70
Trend
Sideways
MACD
Bullish
Bollinger
Within bands
vs 20-day
above
vs 50-day
above
vs 200-day
below
Support
$3.40
Resistance
$5.99
  • Price is above its 50-day average (medium-term uptrend).

Educational technical indicators — not investment advice. TradeOrgs does not place trades.

Signal backtest · 2025-09-29 → 2026-07-02

Strategy return
-41.9%
Buy & hold
-58.3%
Trades
5
Win rate
0%

$100,000.00 invested would be worth $58,079.49 (-41.9%) · Full backtester →

Hypothetical: go long when the signal turns Buy, exit when it turns Sell. Past indicator behavior is not a prediction — educational only, not advice.

About Aardvark Therapeutics, Inc.· Biotechnology

source: yahoo

Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.

Sector
Healthcare
Industry
Biotechnology
Employees
40
Headquarters
San Diego, United States
aardvarktherapeutics.com ↗

Fundamentals· Information Technology

demo data

Live data was unavailable (the free feed can be rate-limited or blocked by region/host), so sample figures are shown. Set FINNHUB_API_KEY for a reliable fallback.

Market cap
$603.58B
P/E
10.1
P/B
1.0
EPS
$35.95
Div yield
1.7%
Profit margin
7.2%
ROE
10.0%
Debt / Equity
0.63
Beta
1.11
52-week range
$253.11 – $451.98
52-week low · $253.110% of rangehigh · $451.98

Recent news

News sentiment:▲ Positive2↑ · 1↓ · 5–
  • Several Insiders Invested In Aardvark Therapeutics Flagging Positive News▲ Positive
    Simply Wall St. · 28 May 2026
  • Sector Update: Healthcare Stocks Decline Late Afternoon▼ Negative
    MT Newswires · 15 May 2026
  • Top Midday Decliners— Neutral
    MT Newswires · 15 May 2026
  • Sector Update: Healthcare Stocks Softer Friday Afternoon

Fundamental data is informational only — not investment advice.

— Neutral
MT Newswires · 15 May 2026
  • Sector Update: Healthcare— Neutral
    MT Newswires · 15 May 2026
  • Sector Update: Healthcare Stocks Mixed Premarket Friday— Neutral
    MT Newswires · 15 May 2026
  • Sentiment is a keyword-based read of the headline — a rough signal, not advice.